Fast Locator 2011-2012: MPI Research - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2011-2012: MPI Research



MPI RESEARCH – Your Responsive CRO

MPI Research, with global headquarters in Mattawan, Michigan, provides discovery, safety evaluation, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. Responsiveness, scientific knowledge, and experience, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization.

Our open and responsive culture is evident in the collegial, collaborative atmosphere at MPI Research. Sponsors find communication with their counterparts within the company to be refreshingly easy, frequent, and informative. Study Directors are uniquely accessible on a real-time basis and proactive in keeping you informed as developments unfold, from collaboration on the initial program design through final report.

A Full Spectrum of Integrated Services
MPI Research has conducted thousands of drug safety, discovery, and bioanalytical and analytical studies. The company’s internal structure allows us to respond and adapt rapidly, from making last minute scheduling changes to developing new capabilities as needed. We test a wide and diverse range of compound classes, provide all routes of administration with the exception of inhalation, and offer studies with numerous species and models. With ample physical and technical capacity, we can accommodate multiple requirements simultaneously, adjust schedules readily, and produce results quickly.

Biologic Expertise
MPI Research built its reputation on its toxicological experience and knowledge with small molecules. However, the company is ahead of the curve in responding to recent market trends with biopharmaceuticals. Our scientific experts understand the many significant ways in which the development process of a large molecule differs from that of traditional small molecules, including immune response, dose solution preparatory considerations, species-specific pharmacologic factors, and delivery methods. MPI Research has the experience and knowledge to meet all of your development needs for both large and small molecules.


Regions Where Services are Offered:

North America, Asia, Europe, and key ROW areas.


Outsourcing serivces provided:

Analytical Services

  • Chemistry & stability
  • Bioanalytical testing
  • Biosafety & product characterization
  • Microbiology

Website:

www.mpiresearch.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications

Click here